Barriers and Facilitators to medication compliance in IBD patients

Details of Research
Contact: Jhananiee Subendran, Research Student
416-586-4800 ext 2159

Primary Investigator: Erin Kennedy, MD
Enrolment: Complete

Objective: The main aim of this study is to explore the perspectives of individuals with IBD in Toronto, Canada on barriers and facilitators to the compliance of medication.

Expectation: This research may lead to a better understanding of lower compliance rates, and suggest possible ways to improve rates.
Eligibility: Anyone over 18 years diagnosed with IBD (Crohn’s Disease, Ulcerative Colitis or Indeterminate Colitis), have been on any type of treatment for at least 2 years, and are currently on an immunomodulator (Methotrexate) or biologic (Remicade/Humira/etc).

Participation: Participation involves a one-time interview ~30 minutes with the coordinator. Refreshments will be provided.

We would like to thank you in advance for your interest and continued support.